14
          
        
        
          DAN ROBERTS
        
        
          PORTFOLIO MANAGER FIDELITY GLOBAL DIVIDEND AND
        
        
          GLOBAL ENHANCED INCOME FUNDS SHARES HIS STRATEGY
        
        
          
            The dividend-paying share
          
        
        
          
            universe is widely represented
          
        
        
          
            across the globe and good quality
          
        
        
          
            companies can now be found paying
          
        
        
          
            well-covered dividends in a range of
          
        
        
          
            sectors and geographies. Investing
          
        
        
          
            globally provides the flexibility to go
          
        
        
          
            where dividends are growing around
          
        
        
          
            the world. Also, importantly, in times
          
        
        
          
            of market volatility, a global equity
          
        
        
          
            income fund can offer a relatively
          
        
        
          
            stable source of return and income
          
        
        
          
            thanks to the dividend.
          
        
        
          Companies with a track record of
        
        
          paying dividends are often more
        
        
          predictable and resilient businesses,
        
        
          which mean their returns can be less
        
        
          volatile than the wider equity market.
        
        
          Don’t overlook Japan
        
        
          Japan is home to a number of
        
        
          conservatively-managed companies
        
        
          with strong balance sheets, many
        
        
          of whom are leaders within their
        
        
          respective industries or niches.
        
        
          As such, the region provides good
        
        
          opportunities for bottom-up stock
        
        
          pickers.
        
        
          Healthcare company Astellas Pharma
        
        
          is a key holding and a good example
        
        
          of a stock which I believe provides the
        
        
          portfolio with a high quality income
        
        
          stream.
        
        
          The company has strong franchises
        
        
          in its core business of urology and
        
        
          transplantation, and its collaboration
        
        
          with US company Medivation on a
        
        
          drug called Xtandi for prostate cancer
        
        
          offers real potential for significant
        
        
          growth. I have owned the stock since
        
        
          the Fidelity Global Dividend Fund
        
        
          launched in January 2012 at which
        
        
          point the dividend yield was 4%.
        
        
          Stock price appreciation has
        
        
          compressed the yield to around
        
        
          2% but the underlying valuation
        
        
          is still attractive and I believe the
        
        
          current dividend payout has room
        
        
          to grow materially. Management are
        
        
          shareholder friendly with a good
        
        
          track record of dividend growth and
        
        
          periodic buybacks.
        
        
          At the market level, it is important to
        
        
          appreciate that Japanese stocks have
        
        
          been steadily de-rated for some 25
        
        
          years. Of course, starting valuations
        
        
          in the late 1980s were egregiously
        
        
          high and explain in large part the poor
        
        
          relative returns we have seen since
        
        
          that time. However, valuations today
        
        
          are now back ‘in the pack’ and the
        
        
          opportunity for stock selection is, in
        
        
          my opinion, very good.
        
        
          There are also encouraging, if nascent,
        
        
          signs of change – mooted reductions
        
        
          in corporate tax rates, long overdue
        
        
          restructuring and even the occasional
        
        
          announcement of share buybacks. As
        
        
          such, I think Japan is a region which
        
        
          shouldn’t be overlooked within a
        
        
          global equity income portfolio.
        
        
          EMERGING MARKETS
        
        
          A glance at the geographic split of the
        
        
          Fidelity Global Dividend and another
        
        
          Fidelity fund - Global Enhanced
        
        
          Income fund - by company domicile
        
        
          shows only a modest 2% allocation to
        
        
          emerging markets.
        
        
          However, the overall exposure is
        
        
          higher than this number would
        
        
          suggest due to a number of holdings
        
        
          in developed markets – companies
        
        
          such as Sanofi and Unilever – deriving
        
        
          a high percentage of their revenues
        
        
          from emerging economies.
        
        
          Although this ‘indirect’ exposure isn’t
        
        
          captured in the headline statistics,
        
        
          understanding the geographic split
        
        
          of revenue streams of holdings in the
        
        
          portfolio is an important part of my
        
        
          analysis.
        
        
          GOING GLOBAL IN THE HUNT FOR SUSTAINABLE DIVIDENDS